KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesOther Gross PP&E AdjustmentsReceivables RefundsShares IssuedShares Outstanding
Ratios

Co-Diagnostics (CODX) Depreciation & Amortization (IS) (2017 - 2025)

Historic Depreciation & Amortization (IS) for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to $267383.0.

  • Co-Diagnostics' Depreciation & Amortization (IS) fell 2387.35% to $267383.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 1025.16%. This contributed to the annual value of $1.4 million for FY2024, which is 1192.97% up from last year.
  • According to the latest figures from Q3 2025, Co-Diagnostics' Depreciation & Amortization (IS) is $267383.0, which was down 2387.35% from $291414.0 recorded in Q2 2025.
  • Co-Diagnostics' Depreciation & Amortization (IS)'s 5-year high stood at $424342.0 during Q2 2022, with a 5-year trough of $67005.0 in Q1 2021.
  • In the last 5 years, Co-Diagnostics' Depreciation & Amortization (IS) had a median value of $298618.0 in 2022 and averaged $266582.3.
  • Per our database at Business Quant, Co-Diagnostics' Depreciation & Amortization (IS) skyrocketed by 49171.43% in 2022 and then plummeted by 2806.6% in 2023.
  • Quarter analysis of 5 years shows Co-Diagnostics' Depreciation & Amortization (IS) stood at $102606.0 in 2021, then surged by 191.03% to $298618.0 in 2022, then increased by 4.78% to $312878.0 in 2023, then increased by 14.14% to $357123.0 in 2024, then dropped by 25.13% to $267383.0 in 2025.
  • Its last three reported values are $267383.0 in Q3 2025, $291414.0 for Q2 2025, and $280445.0 during Q1 2025.